Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In the last decade, there have been significant advances in outcome measure research in psoriatic arthritis (PsA). In this article, the outcome measures for disease activity in individual key domains of PsA are reviewed, followed by the key patient-reported outcome measures of function, quality of life, fatigue, and a new measure for disease impact, the psoriatic arthritis impact of disease. New research into composite measures of psoriatic disease is summarized, including response measures and proposed cutoff points for disease activity. Finally, the key future issues in outcome measurement in PsA are addressed.

Original publication

DOI

10.1016/j.rdc.2015.07.009

Type

Journal article

Journal

Rheum dis clin north am

Publication Date

11/2015

Volume

41

Pages

699 - 710

Keywords

Composite measures, Disease activity, Function, Impact of disease, Outcome measures, Psoriatic arthritis, Quality of life, Antirheumatic Agents, Arthritis, Psoriatic, Humans, Outcome Assessment (Health Care), Quality of Life, Severity of Illness Index